digital pathology
Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research
Indivumed and the Oslo University Hospital's Institute for Cancer Genetics and Informatics will develop algorithms to automate colorectal cancer prognoses.
10x will develop a third genomics platform, possibly combining Cartana's more sensitive chemistry with ReadCoor's instrument.
The company reported on its development of a deep learning model to predict gene expression of tumors from whole slide images without the need to sequence RNA.
The company has developed a microscopy system that allows imaging of a full pathology slide in 21 channels with a single staining process and a rapid turnaround time.
The company plans to market its GeoMx instruments for broader, more discovery-oriented research with a sequencing-based readout.
Nov 4, 2019
NanoString Q3 Revenues Rise 7 Percent
Sep 11, 2019
Feb 26, 2019
May 23, 2013
Cenix, Debiopharm Ink Biomarker ID Deal
Oct 16, 2012
Oct 1, 2012
Definiens Raises $12.9M in Private Financing
Jun 30, 2011
Metamark, Definiens Partner on Cancer Dx
Mar 10, 2011